Naturally Occurring Compounds in Cocoa Tied to Blood Flow Improvements for Adults With Type ...(eusing the Mars Cocoapro(R) process are ...),Health

Date:5/27/2008

e using the Mars Cocoapro(R) process are thoroughly characterized in terms of nutrient content, as well as standardized with respect to flavanol level and flavanol profile. Through the newly created Mars Botanical division, Mars will continue to develop and apply industry-leading analytical techniques and standards to further investigate the biomedical potential of cocoa flavanols. For more information on the many research studies on cocoa flavanols, visit http://www.healthycocoa.com.

A Global Commitment to Cocoa Sustainability

For decades, Mars, Incorporated has helped bring together the cocoa industry with leaders in related fields to create and fund beneficial research programs. Beyond research on the health potential of cocoa, Mars, Incorporated has demonstrated global efforts to bring the positive environmental and socioeconomic benefits of sustainably grown cocoa to farmers, their families and their communities. Programs include education and training for farmers, development of pest/disease resistant cocoa crops and other pioneering avenues for cocoa research. For more information visit http://www.cocoasustainability.mars.com.

Source: Balzer J, Rassaf T, Heiss C, Kleinbongard P, Lauer T, Merx M, Heussen N, Gross HB, Keen CL, Schroeter H, Kelm M. Sustained benefits in vascular function through flavanol-containing cocoa in medicated diabetic patients: A double-masked, randomized, controlled trial. Journal of the American College of Cardiology. 2008; 51:2141-2149.

About Mars, Incorporated

Mars, Incorporated, headquartered in McLean, Virginia is a family-owned company with a strong commitment to science-based research. With more than 15 years of research into the health effects of cocoa flavanols, and decades of research invested into improving the cocoa plant and farming techniques, Mars, Incorporated has
'/>"/>

SOURCE Mars, Incorporated Copyright©2008 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5
Related medicine technology :

1. Derma Sciences to Enter Phase II Development of Wound Healing Product That May Use Bodys Own Naturally Occurring Stem Cells
2. TorreyPines Therapeutics Announces Strategic Plan with Focus on Clinical Development Activities to Maximize Value of Versatile Lead Compounds
3. Caliper Life Sciences Introduces Drug Combination Services to Identify Synergistic Response of Compounds
4. Preclinical Studies Show Potential Progress Toward Identifying Specific Tumor Types With Higher Likelihood of Demonstrating Response to Anti-Cancer Compounds Early in Clinical Development
5. Quark Pharmaceuticals Signs Collaboration Agreement With University of Michigan for Development of Proprietary SiRNA Compounds for Noise-Induced Hearing Loss
6. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
7. New Data Highlighting Possible Impact of ESA Reimbursement Policies on Patient Care, Nations Blood Supply, to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting
8. Pharmacopeias First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients
9. Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations
10. Blood Spot Technology at ZRT Highlighted in March Issue of Journal of Diabetes Science & Technology - A Convenient Alternative to Serum Testing for Health Screening
11. Vermillion and the Ohio State University Report That Novel Diagnostic Test May Help Predict Risk for Relapse of TTP, A Serious Blood Disorder